Chemed Corp. (CHE) Reports In-Line Q1 EPS; Guides FY14 EPS to Strong Side of Consensus

Chemed Corp. (NYSE: CHE) reported Q1 EPS of $1.32, in-line with the analyst estimate of $1.32. Revenue for the quarter came in at $358 million versus the consensus estimate of $256.77 million.

Chemed Corp. sees FY2014 revenue of $5.90-6.10 million, versus the consensus of $5.90 million.

For earnings history and earnings-related data on Chemed Corp. (CHE) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c